Abridge review
The US enterprise ambient-scribe front-runner — $5.3B valuation, 200+ health systems, the deepest Epic embed in the category and a real beyond-documentation roadmap (RCM, prior-auth).
The enterprise front-runner. Abridge partners with 200+ US health systems — Kaiser Permanente (40-hospital generative-AI rollout, the largest in healthcare to date), UPMC (12,000 clinicians by 2026), Mayo Clinic, Johns Hopkins, Duke Health, Mount Sinai. The Epic embed is the deepest in the category — Haiku to Hyperdrive, scribe-inside-Epic rather than alongside — and the platform has extended past documentation into revenue-cycle and prior-authorization automation. $773M raised across six rounds; June 2025's $300M Series E (a16z-led) doubled the valuation to $5.3B on ~$117M ARR. Trade-offs: enterprise sales-led only — no published pricing or self-serve trial, procurement model overkill for solo clinicians, compliance certifications not enumerated on the marketing page, and thin international availability.
- Deepest Epic embed in the category — Haiku to Hyperdrive, scribe-inside-Epic
- 200+ US health systems including Kaiser Permanente, UPMC, Mayo Clinic, Johns Hopkins, Duke Health, Mount Sinai
- Revenue-cycle module and prior-authorization automation — beyond pure documentation
- Auditable "Linked Evidence" trail
- $5.3B valuation (June 2025 $300M Series E, a16z-led); $773M total raised; ~$117M ARR (Q1 2025)
- Multi-specialty — primary care, cardiology, oncology, and broader specialty roll-outs at the IDN scale
- HIPAA + SOC 2 confirmed
- Enterprise sales-led only — no published pricing or self-serve trial
- Procurement model is overkill for solo and small-practice clinicians
- Compliance certifications aren't enumerated on the public marketing page
- International availability thinner than global-multi-region tools
- GDPR posture and EU data residency not publicly stated
How we scored Abridge
Clinical precision and note quality are hands-on tested; integrations, compliance and value are derived from sourced facts. How scoring works.
- Clinical precisiontested
- 7.6
- Note qualitytested
- 7.4
- Integrations
- 9.4
- Compliance & trust
- 9.3
- Pricing & value
- 5.4
Features
Compliance
Data residency: United States (cloud)
Regional & EHR fit
Country availability, named EHR integrations and region-specific details.
Where it's available
Named EHR integrations
Public API: Not disclosed
- Abridge — official site
- Abridge — $300M Series E announcement (a16z-led)
- Abridge scores $300M Series E at $5.3B (Fierce Healthcare, 2025)
- Abridge doubles valuation to $5.3B (TechCrunch, 2025)
- Abridge revenue & valuation profile (Sacra)
Last verified 2026-05-20 · Data confidence: high.
Abridge FAQ
What is Abridge best for?
The US enterprise ambient-scribe front-runner — $5.3B valuation, 200+ health systems, the deepest Epic embed in the category and a real beyond-documentation roadmap (RCM, prior-auth). We rate it best for us health systems and academic medical centers that want the deepest epic embed and an enterprise-grade procurement path.
How much does Abridge cost?
Enterprise contracts only; pricing not publicly disclosed. (Pricing as of 2026-05-20; always confirm current details with the vendor.)
Does Abridge have a free trial or free tier?
Abridge has no free tier. No free trial is publicly listed.
Is Abridge HIPAA and SOC 2 compliant?
Abridge states it is HIPAA compliant. It also states SOC 2 compliance. (Compliance as of 2026-05-20; always confirm current details with the vendor.)
Does Abridge train its AI on your data?
Abridge does not publicly disclose whether it trains on customer data. Confirm this in your contract before deploying.
Which EHRs does Abridge integrate with?
Publicly named: Epic, Oracle Health, athenahealth, MEDITECH, eClinicalWorks, NextGen, AllScripts. API availability is not publicly disclosed.
Where is Abridge available?
US. Data residency: United States (cloud).
Abridge by specialty
Specialty-narrowed takes — the same Abridge review, weighted for what matters in each setting.
Abridge — Head-to-head
The same data, narrower scope — see how Abridge stacks up against the tools clinicians most often weigh against it.
Clinician reviews
No verified reviews yet — be the first.
Review Abridge
Email-verified before publishing. Be specific and fair.